Cassava Sciences Inc.’s stock tumbled 85% Monday to put it on track for its biggest-ever one-day decline, after the clinical-stage biotech company said a trial of a treatment for mild to moderate ...

Cassava Sciences Inc.’s stock crated 85% in premarket trade Monday, after the clinical-stage biotech said a trial of a treatment for mild-to-moderate Alzheimer’s disease failed to meet its main goals.

Discover the Top 10 Passers in the Monster Energy NASCAR Cup Series in this thrilling video! From Chase Elliott’s precision ...

A survey by the Alzheimer's Society has found that many people who experience early signs of dementia mistake them for signs ...

It is critical to recognise dementia early on since it can improve care and quality of life for individuals affected. However ...

Paul Carpenter has created a tracking solution called BoundaryCare, it’s one of a growing number of companies that offer ...

Are there warning signs that I could watch for to help us ... "Someone with early-onset Alzheimer's who is younger than 65 can qualify for fast-track eligibility for Social Security Disability ...

Untreated insufficient sleep can increase the likelihood of depression, cardiovascular disease, type 2 diabetes and, possibly ...

Keir Starmer has admitted he's "not surprised" by two million people signing a petition calling for another general election, ...

Ride-hailing apps like Uber, Lyft and Waymo make it easier for seniors to travel independently without relying on family or ...

Researchers trained computer models to predict everyday events, revealing that responding to uncertainty, rather than just ...